The growth of the elderly population and the incidence of chronic diseases have driven the explosive growth of the implantable and interventional medical device market. According to the latest report, by 2025, the market for implantable medical devices is expected to exceed $138.5 billion. This growth. The Centers for Disease Control and Prevention reports that in the medical field, for the treatment and prevention of sudden diseases, implantable and interventional medical devices provide faster treatment interventions and better outcomes. In recent years, the state has also introduced relevant policies and regulations on multiple occasions, listing implantable and interventional devices as key development areas, vigorously promoting their development, encouraging domestic innovation, and striving to break the monopoly of imports. Meanwhile, the pre-certification of software and pre-market approval (PMA) of implantable, interventional, and active medical devices on the market by the regulatory authority have also provided greater markets and opportunities for medical device manufacturers.

This conference will invite a number of experts from within the industry to discuss the industry prospects, technological innovation, and the difficulties and solutions that may be encountered during the actual production and marketing process of active implantable and interventional devices.